This content is machine translated Cardiac arrhythmias Atrial fibrillation – what do current guidelines say? Atrial fibrillation is the most common sustained cardiac arrhythmia and is associated with significantly increased mortality and morbidity. Therefore, timely diagnostic and therapeutic measures are required. The current ESC guidelines…
View Post 3 min This content is machine translated High-risk cardiology patients Facts and Figures on Antithrombotic Therapy Anticoagulation is associated with many challenges – even more so when patients belong to a high-risk group. This is because the combination of different preparations can be associated with risks,…
View Post 4 min This content is machine translated Pulmonary embolism Anticoagulate hemodynamically unstable patients even on suspicion Patients with pulmonary embolism require anticoagulation for a period of at least three months. Before starting therapy, several considerations must be addressed: Which anticoagulant is the most appropriate for this…
View Post 11 min This content is machine translated Atrial fibrillation Anticoagulation in Atrial Fibrillation – A Brief Update. Oral anticoagulation with the non-vitamin K-dependent oral anticoagulants (NOAKs) in patients with atrial fibrillation is a success story. Since the introduction of these substances in Switzerland almost 10 years ago,…
View Post 1 min This content is machine translated Tumor-associated thromboembolism Oral anticoagulation with NOAKs? Tumor-associated thromboembolism can have fatal consequences. Therefore, effective anticoagulation is indicated in the acute situation and as recurrence prophylaxis. Currently, heparins are recommended. Can NOAKs also be used?
View Post 8 min This content is machine translated Thrombophilia Antiphospholipid syndrome – an update. The systemic autoimmune disease APS (antiphospholipid syndrome) is mainly characterized by thrombotic manifestations. As acquired thrombophilia, variable drug thromboprophylaxis is indicated.
View Post 5 min This content is machine translated ESC Congress 2017, Barcelona Prevention of atrial fibrillation and complications The epidemic scale and serious complications make atrial fibrillation a major threat to cardiovascular health. In addition to vitamin K antagonists, four new oral anticoagulants (NOAKs) are available for stroke…
View Post 6 min This content is machine translated Mechanical vaccination can save lives Atrial appendage closure in patients with atrial fibrillation More than 95% of all emboli in patients with atrial fibrillation originate in the left atrial ear. Atrial appendage closure can be performed by means of a 20-minute procedure under…
View Post 5 min This content is machine translated Zurich Review Course in Clinical Cardiology. Always take syncope in athletes seriously The first day of the Zurich Review Course focused on current news in cardiology. What is the benefit of iron deficiency therapy in heart failure? When should which of the…
View Post 6 min This content is machine translated Symposium Interventional Cardiology Too much of a good thing or not enough? The Interventional Cardiology Symposium at the University Hospital Zurich was also dedicated to anticoagulants and antiplatelet agents. Here, the question was “one, two, or three?” As it turned out, the…
View Post 5 min This content is machine translated 18th Annual Meeting of the Swiss Cerebrovascular Society Cerebral hemorrhagic complications during anticoagulation – how to proceed? Intracranial hemorrhage is one of the most feared complications of oral anticoagulant therapy. At the annual meeting of the Swiss Cerebrovascular Society in Geneva, a lecture was dedicated to this…
